SCHEMBL4124926

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4126974	0.92	GPR119 (0.40)	ACHEHTTMAPTNPC1RAB9A
	SCHEMBL4127264	0.87	ACHE (0.41)	ACHENPC1RAB9ABCHEGRIN2B
	SCHEMBL4132191	0.86	ACHE (0.38)	ACHEHTTBCHECYP3A4CYP2D6
	SCHEMBL4126334	0.86	ACHE (0.36)	ACHEBCHECHRM4
	SCHEMBL4120533	0.85	ACHE (0.41)	ACHEBCHE
	SCHEMBL13596559	0.83	GPR119 (0.42)	ACHE
	SCHEMBL4112826	0.82	ACHE (0.41)	ACHEBCHE
	SCHEMBL13596556	0.82	GPR119 (0.41)	ACHEHTTMAPTNPC1RAB9A
	SCHEMBL4124936	0.81	HTT (0.39)	ACHEHTTMAPTNPC1RAB9A
	SCHEMBL4119957	0.81	ACHE (0.48)	ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.